Prevalence and risk factors for fragility fracture in systemic mastocytosis
Bone Oct 04, 2017
Degboe Y, et al. - This study investigated risk factors related to fragility fractures (FF) in systemic mastocytosis (SM) and, assessed the ability of bone marrow tryptase (BMT) level to detect patients with FF, and to describe bone involvement in SM. The identified markers associated with FF in SM were: low femoral T-score, BMT level, and older age at diagnosis. Furthermore, it was observed that BMT may be a crucial biomarker to predict FF in SM patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries